Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.019 EUR | +0.99% | -1.26% | -1.16% |
Mar. 14 | Pharming Group N.V. Provides Earnings Guidance for the Year 2024 | CI |
Mar. 14 | Pharming Group Seeks Acquisitions | CI |
Business Summary
Pharming Group N.V. serves patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia/Pacific.
Number of employees: 332
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Recombinant Human C1 Esterase Inhibitor
100.0
%
| 168 | 100.0 % | 196 | 100.0 % | +16.28% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
97.3
%
| 164 | 97.3 % | 190 | 97.3 % | +16.34% |
Europe
2.4
%
| 4 | 2.5 % | 5 | 2.4 % | +12.26% |
Rest of the World
0.3
%
| 0 | 0.3 % | 1 | 0.3 % | +33.48% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
Director of Finance/CFO | 55 | 20-11-15 | |
Anurag Relan
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Mireille Sanders
COO | Chief Operating Officer | 56 | 19-04-30 |
Robert Friesen
CTO | Chief Tech/Sci/R&D Officer | 60 | 21-07-31 |
Compliance Officer | 60 | 20-03-31 | |
Michael Levitan
IRC | Investor Relations Contact | 66 | - |
Stephen Toor
PRN | Corporate Officer/Principal | 52 | 20-12-14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Pykett
BRD | Director/Board Member | 61 | 20-12-10 |
Leonard Kruimer
BRD | Director/Board Member | 66 | 21-05-18 |
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
Steven Baert
BRD | Director/Board Member | 50 | 21-03-31 |
Deborah Jorn
BRD | Director/Board Member | 66 | 19-05-21 |
Barbara Yanni
BRD | Director/Board Member | 69 | 20-12-10 |
Director/Board Member | 58 | 21-05-18 | |
Richard Peters
CHM | Chairman | 61 | 23-09-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 669,405,539 | 655,383,865 ( 97.91 %) | 0 | 97.91 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.16% | 733M | |
+33.46% | 701B | |
+26.24% | 571B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 319B | |
+0.74% | 210B | |
+2.95% | 210B | |
-6.05% | 201B | |
-3.61% | 157B |
- Stock
- Equities
- Stock Pharming Group N.V. - Euronext Amsterdam
- Company Pharming Group N.V.